LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL presentations.

Fresenius Kabi announced the launch of Adenosine Injection, USP, 6mg/2mL and 12mg/4mL, in single-dose Simplist ready-to-administer prefilled syringes. Fresenius Kabi announced the launch of Adenosine ...

Astellas currently markets Adenoscan (R) (adenosine injection), the leading pharmacologic stress agent for MPI studies in the United States. Adenoscan is indicated as an adjunct to thallium-201 ...

Adenosine Injection, a pharmacologic stress agent, is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. Fresenius Kabi announced the ...

November 3 2008--LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Food and Drug Administration has granted approval for Akorn's Abbreviated New Drug ...

A double injection of intracoronary adenosine improves myocardial reperfusion as well as early clinical outcomes in patients receiving primary percutaneous coronary intervention (PCI) for acute ...

SAN FRANCISCO (CBS.MW) -- Teva Pharmaceuticals' TEVA, +0.92% stock rose $1.18 to $68.28 Wednesday after the company's abbreviated new drug application for its Adenosine injection was approved by the ...

Fractional flow reserve measurements were similar during intravenous or intracoronary application of adenosine among patients with an intermediate degree of stenosis. Researchers systematically ...

Nicorandil, a vasodilator, appears to effectively induce hyperemia during fractional flow reserve (FFR) measurement with few adverse events. The drug may prove to be a more convenient, safer ...

PALO ALTO, Calif. and DEERFIELD, Ill., April 10 -- CV Therapeutics and Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Lexiscan(TM) (regadenoson) ...